Access Statistics for Izabela Jelovac

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Basic, applied research, and price negotiation for new drugs 0 0 0 0 0 0 5 15
Comparing Organizational Structures in Health Services 0 0 0 0 1 1 7 2,385
Comparing approval procedures for new drugs 0 0 0 0 0 0 5 18
Demand versus Supply Side Cost-Sharing: Patients’ preferences 0 0 0 0 0 0 2 14
Demand versus Supply Side Cost-Sharing: The users' perspective 0 0 0 0 0 0 4 14
Demand versus Supply Side Cost-Sharing: The users' perspective 0 0 0 0 1 2 4 19
Des « Nobels » de sciences économiques au service des systèmes de santé 0 0 0 0 0 0 3 11
Do free-of-charge public health services impede cost recovery policies in Khartoum state, Sudan? 0 0 0 7 0 0 3 87
Drug approval decision times, international reference pricing and access to new drugs 0 0 0 0 0 1 5 15
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 1 6 28
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 0 10 28
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 1 7 26
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 1 3 11 0 2 16 50
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 0 4 24
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 6 1 1 8 46
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 0 9 32
Drug approval decision times, international reference pricing and strategic launches of new drugs 0 0 0 0 0 0 5 27
Drug launch timing and international reference pricing 0 0 0 0 0 0 2 18
Drug launch timing and international reference pricing 0 0 0 0 1 3 13 33
Drug launch timing and international reference pricing 0 0 0 17 0 0 2 80
Drug launch timing and international reference pricing 0 0 0 0 0 1 5 39
Drug launch timing and international reference pricing 0 0 0 0 0 1 4 22
Drug launch timing and international reference pricing 0 0 0 0 1 2 5 18
Drug launch timing and international reference pricing 0 0 0 33 0 0 3 59
Enjeux tarifaires de la médecine génomique 0 0 0 0 0 0 6 15
External Reference Pricing and Sequential Launching of Drugs 0 0 0 0 0 0 2 27
External referencing and pharmaceutical price negotiation 0 1 4 5 0 2 10 26
External referencing and pharmaceutical price negotiation 0 0 0 148 0 0 4 448
External referencing and pharmaceutical price negotiation 0 0 0 0 0 0 3 26
GPs’ Payment Contracts and their Referral Policy 0 0 0 13 2 3 8 84
Health Services: Incentives and Access. Keynote speech 0 0 0 0 0 0 5 17
Health services: Incentives and access 0 0 0 0 0 0 4 14
Healthcare providers’ payments with personalized medicine 0 0 0 0 0 0 2 6
How Should Donors Give Foreign Aid? Project Aidversus Budget Support 0 0 0 62 1 3 8 355
How should donors give foreign aid ? A theoretical comparison of aid modalities 0 0 0 0 0 0 2 16
How should donors give foreign aid? Project aid versus budget support 0 0 1 110 1 2 7 270
How should donors give foreign aid? Project aid versus budget support 1 3 3 169 3 7 13 625
Incentives to patients versus incentives to health care providers: The users' perspective 0 0 0 0 0 2 2 29
Incentives to patients versus incentives to health care providers: The users' perspective 0 0 0 17 0 2 4 37
Incentives to patients versus incentives to health care providers: The users' perspective 0 0 0 0 1 2 5 20
Incentives to patients versus incentives to health care providers: The users’ perspective 0 0 0 26 0 5 11 54
La Médecine personnalisée 0 0 0 0 2 3 4 28
Médecine personnalisée et prix des médicaments 0 0 0 0 0 0 2 17
On the relationship between the negociated price of pharmaceuticals and the patients' co-payment 0 0 0 0 1 1 2 20
On the relationship between the negociated price of pharmaceuticals and the patients' co-payment 0 0 0 0 1 3 9 50
Payment mechanism and GP self-selection: capitation versus fee for service 0 0 0 0 1 2 8 47
Perception du lien entre mode de rémunération et comportement des médecins 0 0 0 0 0 0 6 26
Perception du lien entre mode de rémunération et comportement des médecins 0 0 0 0 0 0 4 26
Personalized medicine and drug prices 0 0 0 0 0 0 3 29
Physicians Balance Billing, Supplemental Insurance and Access to Health Care 0 0 0 0 1 1 5 40
Physicians Balance Billing, Supplemental Insurance and Access to Health Care 0 0 0 0 0 0 6 38
Physicians Balance Billing, Supplemental Insurance and Access to Health Care 0 0 0 0 0 0 1 23
Physicians Balance Billing, Supplemental Insurance and Access to Health Care 0 0 0 0 1 1 5 45
Physicians self selection of a payment mechanism: Capitation versus fee-for-service 0 0 3 29 1 1 5 80
Physicians self selection of a payment mechanism: Capitation versus fee-for-service 0 0 0 29 3 5 14 257
Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance 0 0 0 0 0 2 2 13
Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance 0 0 0 0 0 0 1 11
Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance 0 0 0 0 0 0 0 9
Physicians' balance billing, supplemental insurance and access to health care 0 0 1 13 2 2 6 80
Physicians’ balance billing, supplemental insurance and access to health care 0 0 0 27 1 1 4 111
Physicians’ balance billing, supplemental insurance and access to health care 0 0 0 0 1 2 3 42
Preferences for Demand versus Supply Side Cost-Sharing 0 0 0 0 0 0 3 12
Pricing and Welfare of Parallel Imports in the Pharmaceutical Industry 0 0 1 163 0 2 6 433
Primary Care, Gatekeeping and Incentives 0 0 0 0 1 2 5 68
Regulation and Altruism 0 0 1 29 4 7 17 40
Regulation and Altruism 0 0 0 25 0 1 7 29
Regulation and altruism 0 0 0 27 1 5 15 36
Regulation and altruism 0 0 0 9 2 3 16 28
Research funding and price negotiation for new drugs 0 0 0 0 0 0 2 2
Research funding and price negotiation for new drugs 0 0 0 0 0 1 4 4
Research funding and price negotiation for new drugs 0 0 0 0 0 0 5 14
Research funding and price negotiation for new drugs 0 0 0 53 0 1 8 25
Research funding and price negotiation for new drugs 0 0 0 0 0 0 3 3
Research funding and price negotiation for new drugs 0 0 1 44 0 0 5 9
Research funding and price negotiation for new drugs 0 0 0 0 0 0 5 15
Research funding and price negotiation for new drugs 0 0 0 0 0 5 7 7
Treatment and referral decisions under different physician payment mechanisms 0 0 0 38 1 2 8 99
Total Working Papers 1 5 18 1,110 37 97 439 6,993


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comparing approval procedures for new drugs 2 2 4 6 2 2 5 12
Comparing organizational structures in health services 1 1 2 123 1 1 9 352
Drug Launch Timing and International Reference Pricing 0 0 0 9 0 1 5 27
External referencing and pharmaceutical price negotiation 0 0 1 35 0 3 9 161
GPs' payment contracts and their referral practice 0 0 2 80 2 3 7 276
Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality 0 0 0 32 0 2 7 120
How Should Donors Give Foreign Aid? A Theoretical Comparison of Aid Modalities 0 0 6 15 0 2 10 33
Incentives to patients versus incentives to health care providers: The users' perspective 0 0 0 1 0 2 3 8
On the relationship between the negotiated prices of pharmaceuticals and the patients' co-payment 0 0 2 22 2 3 8 81
Payment mechanism and GP self-selection: capitation versus fee for service 0 0 1 16 2 9 24 205
Physicians' payment contracts, treatment decisions and diagnosis accuracy 0 0 0 1 1 3 4 184
Physicians’ balance billing, supplemental insurance and access to health care 0 0 0 8 2 5 10 54
Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry 0 0 0 123 0 1 4 318
Regulation and altruism 0 0 0 0 1 1 11 11
Treatment and referral decisions under different physician payment mechanisms 0 1 2 18 2 4 8 98
Total Journal Articles 3 4 20 489 15 42 124 1,940


Statistics updated 2021-01-03